![]() |
Volumn 51, Issue 6, 2001, Pages 2007-2012
|
Mycobacterium doricum sp. nov.
a
|
Author keywords
Identification; Mycobacterium doricum sp. nov.; Phylogeny; Taxonomy
|
Indexed keywords
AMIKACIN;
AMPHOTERICIN B;
ANTIMYCOBACTERIAL AGENT;
AZITHROMYCIN;
CIPROFLOXACIN;
CLARITHROMYCIN;
CLOFAZIMINE;
ETHAMBUTOL;
FLUCYTOSINE;
ISONIAZID;
LIPID;
OFLOXACIN;
RIBOSOME DNA;
RIFABUTIN;
RIFAMPICIN;
SPARFLOXACIN;
STREPTOMYCIN;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ADULT;
ANTIBIOTIC SENSITIVITY;
ARTICLE;
BACTERIAL GROWTH;
BACTERIUM ISOLATION;
CASE REPORT;
CEREBROSPINAL FLUID;
CONTROLLED STUDY;
CRYPTOCOCCOSIS;
CRYPTOCOCCUS NEOFORMANS;
DISEASE SEVERITY;
GENE SEQUENCE;
HUMAN;
IMMUNE DEFICIENCY;
LIPID COMPOSITION;
MALE;
MYCOBACTERIUM;
MYCOBACTERIUM DORICUM;
NEUROLOGY;
NONHUMAN;
NUCLEOTIDE SEQUENCE;
PATHOGENICITY;
PRIORITY JOURNAL;
SYMPTOMATOLOGY;
BACTERIA (MICROORGANISMS);
CORYNEBACTERINEAE;
CRYPTOCOCCUS NEOFORMANS;
FILOBASIDIELLA NEOFORMANS;
MYCOBACTERIUM;
MYCOBACTERIUM DORICUM;
POSIBACTERIA;
|
EID: 0035200202
PISSN: 14665026
EISSN: None
Source Type: Journal
DOI: 10.1099/00207713-51-6-2007 Document Type: Article |
Times cited : (20)
|
References (21)
|